A novel haemocytometric COVID-19 prognostic score developed and validated in an observational multicentre European hospital-based study

A novel haemocytometric COVID-19 prognostic score developed and validated in an observational multicentre European hospital-based study

COVID-19 induces haemocytometric changes. Complete blood count changes, including new cell activation parameters, from 982 confirmed COVID-19 adult patients from 11 European hospitals were retrospectively analysed for distinctive patterns based on age, gender, clinical severity, symptom duration, an...

Full description

Bibliographic Details
Main Authors: Joachim Linssen, Anthony Ermens, Marvin Berrevoets, Michela Seghezzi, Giulia Previtali, Simone van der Sar-van der Brugge, Henk Russcher, Annelies Verbon, Judith Gillis, Jürgen Riedl, Eva de Jongh, Jarob Saker, Marion Münster, Imke CA Munnix, Anthonius Dofferhof, Volkher Scharnhorst, Heidi Ammerlaan, Kathleen Deiteren, Stephan JL Bakker, Lucas Joost Van Pelt, Yvette Kluiters-de Hingh, Mathie PG Leers, Andre J van der Ven
Format: Article
Language:English
Published: eLife Sciences Publications Ltd 2020-11-01
Series:eLife
Subjects:
COVID-19
prognostic score
haemocytometry
complete blood count
intensive care
Online Access:https://elifesciences.org/articles/63195

Internet

https://elifesciences.org/articles/63195

Similar Items